CRMD vs JCI · P/E 3.9, rev $43.5M vs P/E 44, rev $23.60B
CorMedix Inc (CRMD) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the CRMD and JCI stock pages for the full models.
Not investment advice.